Colorcon Ventures Invests In Novome Biotechnologies, An Engineered Microbial Therapy Company
Round Type
Funding Round
San FranciscoBiotechnologyHealth CareTherapeuticsDescription
Colorcon Ventures, the corporate venture fund of Colorcon Inc., has invested in Novome Biotechnologies, a clinical-stage company that develops engineered oral microbial therapies. The company's novel delivery platform controls the colonization of therapeutically engineered bacteria, enabling first-in-class treatment of chronic disorders such as inflammatory bowel disease and enteric hyperoxaluria.
Quick answer
Novome raised an undisclosed amount in a Funding Round round, dated September 15, 2022. Novome is based in San Francisco, California, United States.
- How much did Novome raise?
- Novome raised an undisclosed amount in a Funding Round round on September 15, 2022.
- What does Novome do?
- Novome Biotechnologies is a biotechnology company developing engineered cellular therapies for the gut to treat chronic diseases.
- Where is Novome based and how big is it?
- Novome is based in San Francisco, California, United States.
Source: Fundz verified event record.
Who else raised in Therapeutics and Biotechnology around the same time
Companies in the same sectors as Novome that raised within 45 days of this round, from Fundz verified event records.
- Biofrontera raised $3.7M (Seed) on October 25, 2022.
- MapLight Therapeutics raised $12M on October 25, 2022.
- Insmed Incorporated raised an undisclosed amount (Funding Round) on October 19, 2022.
- Orionis Biosciences raised $55M (Funding Round) on October 19, 2022.
- SURGE Therapeutics raised $26M (Series A) on October 17, 2022.
- Mablink Bioscience raised $30M (Series A) on October 14, 2022.
Who to call at Novome, and when
A new round usually means Novome is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Novome raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Novome, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Novome. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Novome raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Novome raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.